Neurologists at a memory clinic in China have diagnosed a 19-year-old with what they believe to be Alzheimer's disease, making him the youngest person to be diagnosed with the condition in the world.
, which causes abnormal proteins to build up in the brain, forming clumps of toxic plaques, a common feature of Alzheimer's.
Cases like this latest one in China pose something of a mystery. None of the 19-year-old's family had a history of Alzheimer's or dementia, making it hard to categorize as FAD, yet the teenager had no other diseases, infections, or head trauma that could explain his sudden cognitive decline either. Ultimately, the cognitive decline became so bad, the young man was unable to finish high school, although he could still live independently.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘The Eternal Memory’ Review: Delicate Alzheimer’s Doc Balances Personal Reflection and Historical ConsciousnessThrough films as varied as “The Father,” “Dick Johnson is Dead” and “Relic,” dementia and neurodegenerative disease have been extensively portrayed on screen in …
Read more »
New Blood Test Detects Alzheimer’s Disease 3.5 Years Before Clinical DiagnosisA blood-based test could be used to predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London. The study, published on January 27 in the journal Brain
Read more »
69-year-old man with Alzheimer’s disease missing from BellevueBellevue police are asking for the public’s help to find a man with Alzheimer’s disease who walked away from his home on Monday morning.
Read more »
Biogen sees modest 2023 revenue from Alzheimer's disease drugBiogen Inc said on Wednesday that Alzheimer's disease drug Leqembi would bring in modest revenue for the year although it might not be enough to offset costs tied to its launch.
Read more »
Biogen CEO bets on Alzheimer's drug, pipeline to return to growthBiogen Inc Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking on high-profile launches of Alzheimer's disease treatment Leqembi and depression drug zuranolone, as well as deals, to help the company return to revenue growth.
Read more »
Active compound in an edible mushroom is found to boost memoryAn active compound found in an edible mushroom may just be able to improve nerve growth and enhance memory leading to treatments for debilitating diseases such as Alzheimer’s.
Read more »